LBX Pharmacy Chain JSC (SHSE:603883) Cyclically Adjusted Revenue per Share: ¥22.64 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603883 LBX Pharmacy Chain JSC SHSE:603883
70 GF Score
Price ¥12.39
GF Value ¥18.84
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is LBX Pharmacy Chain JSC Cyclically Adjusted Revenue per Share?

LBX Pharmacy Chain JSC SHSE:603883 70 Cyclically Adjusted Revenue per Share is ¥22.64 as of Mar. 2026. GuruFocus rates SHSE:603883 with a GF Score™ of 70/100 and a GF Value™ of ¥18.84 (Significantly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

LBX Pharmacy Chain JSC's adjusted revenue per share for the three months ended in Mar. 2026 was ¥7.271. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥22.64 for the trailing ten years ended in Mar. 2026.

During the past 12 months, LBX Pharmacy Chain JSC's average Cyclically Adjusted Revenue Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-09), LBX Pharmacy Chain JSC's current stock price is ¥12.39. LBX Pharmacy Chain JSC's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ¥22.64. LBX Pharmacy Chain JSC's Cyclically Adjusted PS Ratio of today is 0.55.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LBX Pharmacy Chain JSC was 1.69. The lowest was 0.49. And the median was 0.92.


LBX Pharmacy Chain JSC  (SHSE:603883) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LBX Pharmacy Chain JSC's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.39/22.64
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LBX Pharmacy Chain JSC was 1.69. The lowest was 0.49. And the median was 0.92.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


LBX Pharmacy Chain JSC Cyclically Adjusted Revenue per Share Related Terms


LBX Pharmacy Chain JSC Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for LBX Pharmacy Chain JSC's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LBX Pharmacy Chain JSC Cyclically Adjusted Revenue per Share Chart

LBX Pharmacy Chain JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 17.92 19.89 22.06

LBX Pharmacy Chain JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.39 20.84 21.46 22.06 22.64

LBX Pharmacy Chain JSC Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBX Pharmacy Chain JSC Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LBX Pharmacy Chain JSC's Cyclically Adjusted PS Ratio falls into.


SHSE:603883
70GF Score
LBX Pharmacy Chain JSC SHSE:603883
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LBX Pharmacy Chain JSC Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, LBX Pharmacy Chain JSC's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.271/116.3033*116.3033
=7.271

Current CPI (Mar. 2026) = 116.3033.

LBX Pharmacy Chain JSC Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.231 101.400 2.559
201609 2.477 102.400 2.813
201612 2.793 102.600 3.166
201703 2.707 103.200 3.051
201706 2.788 103.100 3.145
201709 2.846 104.100 3.180
201712 3.439 104.500 3.827
201803 3.293 105.300 3.637
201806 3.319 104.900 3.680
201809 3.436 106.600 3.749
201812 4.031 106.500 4.402
201903 4.049 107.700 4.372
201906 4.176 107.700 4.510
201909 4.190 109.800 4.438
201912 4.510 111.200 4.717
202003 4.852 112.300 5.025
202006 5.039 110.400 5.308
202009 4.564 111.700 4.752
202012 5.571 111.500 5.811
202103 5.298 112.662 5.469
202106 7.173 111.769 7.464
202109 7.180 112.215 7.442
202112 6.242 113.108 6.418
202203 5.401 114.335 5.494
202206 8.418 114.558 8.546
202209 4.303 115.339 4.339
202212 8.682 115.116 8.772
202303 7.183 115.116 7.257
202306 7.141 114.558 7.250
202309 6.729 115.339 6.785
202312 8.710 114.781 8.826
202403 7.242 115.227 7.310
202406 7.121 114.781 7.215
202409 7.016 115.785 7.047
202412 7.897 114.893 7.994
202503 7.156 115.116 7.230
202506 6.927 114.907 7.011
202509 7.202 115.471 7.254
202512 7.814 115.832 7.846
202603 7.271 116.303 7.271

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥22.64 mean?
LBX Pharmacy Chain JSC (SHSE:603883) has a Cyclically Adjusted Revenue per Share of ¥22.64 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on LBX Pharmacy Chain JSC and its competitors.
Is LBX Pharmacy Chain JSC's Cyclically Adjusted Revenue per Share too high?
LBX Pharmacy Chain JSC's current Cyclically Adjusted Revenue per Share is ¥22.64. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's Cyclically Adjusted Revenue per Share compare to competitors?
LBX Pharmacy Chain JSC's Cyclically Adjusted Revenue per Share of ¥22.64 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on LBX Pharmacy Chain JSC and its competitors. LBX Pharmacy Chain JSC's current Cyclically Adjusted Revenue per Share is ¥22.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥18.84, compared to a current price of ¥12.39 — trading 34.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥22.64. LBX Pharmacy Chain JSC's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current Cyclically Adjusted Revenue per Share is ¥22.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?

Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued. The current stock price of ¥12.39 is trading 34.2% below its estimated GF Value™ of ¥18.84. GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.

Key valuation signals for SHSE:603883:

  • Cyclically Adjusted Revenue per Share: ¥22.64
  • GF Value™: ¥18.84 vs. price of ¥12.39 (34.2% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LBX Pharmacy Chain JSC Business Description

Address No. 288, Xiangya Road, Kaifu District, Hunan, Changsha, CHN, 410005
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
70GF Score

Get the complete analysis for SHSE:603883

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.39
Price
¥18.84
GF Value